Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D001500:BCG Vaccine; D002464:Cell Migration Inhibition; D002465:Cell Movement / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006386:Hemagglutination Tests; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007114:Immunization; D066298:In Vitro Techniques; D008168:Lung / Q000473:pathology; D008297:Male; D009169:Mycobacterium tuberculosis; D009336:Necrosis; D010455:Peptides; D011135:Polysaccharides, Bacterial; D011650:Pulmonary Alveoli / Q000473:pathology; D011817:Rabbits; D012756:Sheep / Q000276:immunology; D014373:Tuberculin; D014374:Tuberculin Test; D014375:Tuberculoma / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*
D000888:Antibodies, Anti-Idiotypic; D001500:BCG Vaccine; D010455:Peptides; D011135:Polysaccharides, Bacterial; D014373:Tuberculin